Challenges and Potential Impact of GLP1 Receptor Agonists

While GLP1 agonists hold promise, there are obstacles to their wider usage. The high cost of the drugs, with prices exceeding $1,000 per month, alongside limited insurance coverage, presents a financial barrier for many patients. Furthermore, the long-term effects and necessary habit changes associated with sustained weight loss remain uncertain. Scientists are actively researching the best approaches for long-term weight management with GLP1 agonists, including exercise, diet, and preserving lean muscle mass. Despite these challenges, the drugs' potential to transform healthcare and address various health conditions make them a subject of significant interest and ongoing research.